346 related articles for article (PubMed ID: 15138562)
21. HER2 (erbB-2)-targeted effects of the omega-3 polyunsaturated fatty acid, alpha-linolenic acid (ALA; 18:3n-3), in breast cancer cells: the "fat features" of the "Mediterranean diet" as an "anti-HER2 cocktail".
Menéndez JA; Vázquez-Martín A; Ropero S; Colomer R; Lupu R
Clin Transl Oncol; 2006 Nov; 8(11):812-20. PubMed ID: 17134970
[TBL] [Abstract][Full Text] [Related]
22. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S
J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691
[TBL] [Abstract][Full Text] [Related]
23. Decreased response to paclitaxel versus docetaxel in HER-2/neu transfected human breast cancer cells.
Witters LM; Santala SM; Engle L; Chinchilli V; Lipton A
Am J Clin Oncol; 2003 Feb; 26(1):50-4. PubMed ID: 12576925
[TBL] [Abstract][Full Text] [Related]
24. Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A.
Ueno NT; Yu D; Hung MC
Oncogene; 1997 Aug; 15(8):953-60. PubMed ID: 9285690
[TBL] [Abstract][Full Text] [Related]
25. The effect of seal oil on paclitaxel induced cytotoxicity and apoptosis in breast carcinoma MCF-7 and MDA-MB-231 cell lines.
Wang Z; Butt K; Wang L; Liu H
Nutr Cancer; 2007; 58(2):230-8. PubMed ID: 17640170
[TBL] [Abstract][Full Text] [Related]
26. Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.
Tanabe K; Kim R; Inoue H; Emi M; Uchida Y; Toge T
Int J Oncol; 2003 Apr; 22(4):875-81. PubMed ID: 12632082
[TBL] [Abstract][Full Text] [Related]
27. Enhanced tight junction function in human breast cancer cells by antioxidant, selenium and polyunsaturated lipid.
Martin TA; Das T; Mansel RE; Jiang WG
J Cell Biochem; 2007 May; 101(1):155-66. PubMed ID: 17243118
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of lipid peroxidation in cancer cells in response to gamma-linolenic acid (GLA) analyzed by GC-MS(I): Conjugated dienes with peroxyl (or hydroperoxyl) groups and cell-killing effects.
Takeda S; Sim PG; Horrobin DF; Sanford T; Chisholm KA; Simmons V
Anticancer Res; 1993; 13(1):193-9. PubMed ID: 8386494
[TBL] [Abstract][Full Text] [Related]
29. Lipid peroxidation in human breast cancer cells in response to gamma-linolenic acid and iron.
Takeda S; Horrobin DF; Manku M; Sim PG; Ells G; Simmons V
Anticancer Res; 1992; 12(2):329-33. PubMed ID: 1316091
[TBL] [Abstract][Full Text] [Related]
30. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
[TBL] [Abstract][Full Text] [Related]
31. Synergistic inhibition of breast cancer cell lines with a dual inhibitor of EGFR-HER-2/neu and a Bcl-2 inhibitor.
Witters LM; Witkoski A; Planas-Silva MD; Berger M; Viallet J; Lipton A
Oncol Rep; 2007 Feb; 17(2):465-9. PubMed ID: 17203189
[TBL] [Abstract][Full Text] [Related]
32. Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: relationship to peroxides and vitamin-E.
Chajès V; Sattler W; Stranzl A; Kostner GM
Breast Cancer Res Treat; 1995 Jun; 34(3):199-212. PubMed ID: 7579484
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of the combination of HER-2 antisense oligonucleotide and chemotherapeutic agents used for the treatment of human breast cancer.
Rait AS; Pirollo KF; Rait V; Krygier JE; Xiang L; Chang EH
Cancer Gene Ther; 2001 Oct; 8(10):728-39. PubMed ID: 11687896
[TBL] [Abstract][Full Text] [Related]
34. Docetaxel enhances the cytotoxicity of anthracyclines by increasing intracellular drug accumulation.
Egawa T; Kubota T; Suto A; Otani Y; Furukawa T; Watanabe M; Kumai K; Kitajima M
Oncol Rep; 2002; 9(4):777-81. PubMed ID: 12066208
[TBL] [Abstract][Full Text] [Related]
35. In vitro comparative evaluation of trastuzumab (Herceptin) combined with paclitaxel (Taxol) or docetaxel (Taxotere) in HER2-expressing human breast cancer cell lines.
Merlin JL; Barberi-Heyob M; Bachmann N
Ann Oncol; 2002 Nov; 13(11):1743-8. PubMed ID: 12419746
[TBL] [Abstract][Full Text] [Related]
36. Effects of linoleic acid and gamma-linolenic acid on the growth and metastasis of a human breast cancer cell line in nude mice and on its growth and invasive capacity in vitro.
Rose DP; Connolly JM; Liu XH
Nutr Cancer; 1995; 24(1):33-45. PubMed ID: 7491296
[TBL] [Abstract][Full Text] [Related]
37. Fluvastatin enhancement of trastuzumab and classical cytotoxic agents in defined breast cancer cell lines in vitro.
Budman DR; Tai J; Calabro A
Breast Cancer Res Treat; 2007 Jul; 104(1):93-101. PubMed ID: 17004104
[TBL] [Abstract][Full Text] [Related]
38. HER-2/neu expression as a predictor of response to neoadjuvant docetaxel in patients with operable breast carcinoma.
Learn PA; Yeh IT; McNutt M; Chisholm GB; Pollock BH; Rousseau DL; Sharkey FE; Cruz AB; Kahlenberg MS
Cancer; 2005 Jun; 103(11):2252-60. PubMed ID: 15834928
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
[TBL] [Abstract][Full Text] [Related]
40. Pharmacometabolomics of docetaxel-treated human MCF7 breast cancer cells provides evidence of varying cellular responses at high and low doses.
Bayet-Robert M; Morvan D; Chollet P; Barthomeuf C
Breast Cancer Res Treat; 2010 Apr; 120(3):613-26. PubMed ID: 19513827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
